Varshney N, Singh S, Kandpal M, Saini V, Roberston E, Jha H
BMC Cancer. 2025; 25(1):143.
PMID: 39856614
PMC: 11762537.
DOI: 10.1186/s12885-024-13260-z.
Lee S, Oh H
Sci Rep. 2024; 14(1):30932.
PMID: 39730741
PMC: 11680954.
DOI: 10.1038/s41598-024-81764-6.
Kojima Y, Hamada M, Naruse A, Goto K, Khine H, Arai H
J Gastroenterol. 2024; 60(1):55-65.
PMID: 39572460
DOI: 10.1007/s00535-024-02170-3.
Gu Q, Wu H, Cheng Z, Zhi X, Song Q, Chen X
Dis Markers. 2024; 2022:5588043.
PMID: 39291183
PMC: 11407894.
DOI: 10.1155/2022/5588043.
Zhao X, Huang X, Dang C, Wang X, Qi Y, Li H
Oncol Res. 2024; 32(5):999-1009.
PMID: 38686046
PMC: 11055990.
DOI: 10.32604/or.2024.046679.
The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape.
Salnikov M, MacNeil K, Mymryk J
Front Immunol. 2024; 15:1358511.
PMID: 38596668
PMC: 11002251.
DOI: 10.3389/fimmu.2024.1358511.
Gastric Cancer in the Era of Epigenetics.
Christodoulidis G, Koumarelas K, Kouliou M, Thodou E, Samara M
Int J Mol Sci. 2024; 25(6).
PMID: 38542354
PMC: 10970362.
DOI: 10.3390/ijms25063381.
Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study.
Kim J, Kim N, Song D, Choi Y, Jeon E, Kim S
Gastric Cancer. 2024; 27(2):221-234.
PMID: 38212543
PMC: 10896815.
DOI: 10.1007/s10120-023-01460-8.
Epstein-Barr virus infection: the micro and macro worlds.
Huang W, Bai L, Tang H
Virol J. 2023; 20(1):220.
PMID: 37784180
PMC: 10546641.
DOI: 10.1186/s12985-023-02187-9.
Systemic Diseases and Gastrointestinal Cancer Risk.
Malkani N, Rashid M
J Cancer Allied Spec. 2023; 9(2):473.
PMID: 37575213
PMC: 10405983.
DOI: 10.37029/jcas.v9i2.473.
Critical involvement of circular RNAs in virus-associated cancers.
Zebardast A, Latifi T, Shirzad M, Goodarzi G, Fana S, Tehrani S
Genes Dis. 2023; 10(6):2296-2305.
PMID: 37554189
PMC: 10404876.
DOI: 10.1016/j.gendis.2022.04.009.
Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virus-associated gastric cancer.
Pan Y, Lu L, Liu H, Chen D, Han N, Yao R
Front Immunol. 2022; 13:1003859.
PMID: 36353623
PMC: 9639782.
DOI: 10.3389/fimmu.2022.1003859.
Deep learning model to predict Epstein-Barr virus associated gastric cancer in histology.
Jeong Y, Cho C, Kim J, Lee J, Kim N, Jung W
Sci Rep. 2022; 12(1):18466.
PMID: 36323712
PMC: 9630260.
DOI: 10.1038/s41598-022-22731-x.
Treatment Response Predictors of Neoadjuvant Therapy for Locally Advanced Gastric Cancer: Current Status and Future Perspectives.
Sato Y, Okamoto K, Kawaguchi T, Nakamura F, Miyamoto H, Takayama T
Biomedicines. 2022; 10(7).
PMID: 35884916
PMC: 9312565.
DOI: 10.3390/biomedicines10071614.
Epstein-Barr virus-associated gastric adenosquamous carcinoma with concurrent gastric carcinoma with lymphoid stroma: a case report and review of the literature.
Cao F, Yan Y, Niu D, Huang X, Jia L, Diao X
BMC Gastroenterol. 2022; 22(1):346.
PMID: 35842595
PMC: 9287910.
DOI: 10.1186/s12876-022-02417-4.
Gastric Cancer and Viruses: A Fine Line between Friend or Foe.
Firoz A, Ali H, Rehman S, Rather I
Vaccines (Basel). 2022; 10(4).
PMID: 35455349
PMC: 9025827.
DOI: 10.3390/vaccines10040600.
PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis.
Lima A, Sousa H, Medeiros R, Nobre A, Machado M
Discov Oncol. 2022; 13(1):19.
PMID: 35318527
PMC: 8941030.
DOI: 10.1007/s12672-022-00479-0.
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
Biesma H, Soeratram T, Sikorska K, Caspers I, van Essen H, Egthuijsen J
Gastric Cancer. 2022; 25(3):640-651.
PMID: 35129727
PMC: 9013342.
DOI: 10.1007/s10120-022-01280-2.
Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives.
Charalampakis N, Tsakatikas S, Schizas D, Kykalos S, Tolia M, Fioretzaki R
World J Gastrointest Oncol. 2022; 14(1):181-202.
PMID: 35116110
PMC: 8790425.
DOI: 10.4251/wjgo.v14.i1.181.
Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein-Barr Virus Associated Gastric Cancer: A Retrospective Study.
Xie T, Peng Z, Liu Y, Zhang Z, Zhang X, Li J
Front Oncol. 2021; 11:611676.
PMID: 34631508
PMC: 8495155.
DOI: 10.3389/fonc.2021.611676.